The down-regulation of GNMT can be through the DNA methylation of its promoter region and microRNA-mediated post-transcriptional regulation in disease models and clinical studies, liver fibrosis and cirrhosis, and HCC [45,46]. The gene discussed is GNMT; the disease is Cirrhosis.